News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–40
Matches
40
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

40 matching headlines

Ticker or company: ELVNMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Traders Daily Market update Main company 🇺🇸 United States

How Enliven Therapeutics Inc. (ELVN) Affects Rotational Strategy Timing

This article analyzes Enliven Therapeutics Inc. (ELVN) and its impact on rotational strategy timing, highlighting strong sentiment across all time horizons. It provides AI-generated trading strategies including position trading, momentum breakout, and risk hedging, along with detailed multi-timeframe signal analysis. The report suggests compelling …

ELVN main company
Sharemaestro market context Trend signal active 52 weeks +182.1% ELVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Nigeria Market update Main company 🇺🇸 United States

Form 144 Enliven Therapeutics For: 17 July By Investing.com

This article from Investing.com reports on a Form 144 filing for Enliven Therapeutics (ELVN) on July 17. The brief piece indicates that ELVN saw a 4.60% increase, providing only the date and the company's stock performance. Additional content focuses on market data for various …

ELVN main company
Sharemaestro market context Trend signal active 52 weeks +182.1% ELVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Enliven Therapeutics (ELVN) investor Helen Collins plans sale of 15,000 shares

Helen Collins, a shareholder of Enliven Therapeutics (ELVN), intends to sell 15,000 shares of common stock through Jefferies LLC, valued at approximately $762,900. These shares were acquired via stock options in August 2022. Collins has previously sold 10,000 ELVN shares in the last three …

ELVN main company
Sharemaestro market context Trend signal active 52 weeks +182.1% ELVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Enliven Therapeutics stock hits 52-week high at 52.47 USD

Enliven Therapeutics (ELVN) has reached a new 52-week high of $52.47, reflecting a significant year-to-date return of 236% and a 143.2% increase over the past year. Despite this surge, InvestingPro data suggests the stock appears overvalued relative to its Fair Value. The company recently …

ELVN main company
Sharemaestro market context Trend signal active 52 weeks +182.1% ELVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context